in this issue
Regions :: Western Europe :: Netherlands
Aspen Pharmacare in talks for Merck API facility in the Netherlands
10:08 AM MST | February 4, 2013 | Francinia Protti-Alvarez
Aspen PharmaCare (Durban, South Africa) is in discussions with Merck Sharp Dohme (MSD; Darmstadt, Germany) regarding a possible acquisition of a Merck active pharmaceutical ingredient (API) facility in the Netherlands and a related portfolio of pharmaceutical finished dose form products, Aspen announced today. No further details were immediately...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee